pharmaceutical preparations for target delivery of small molecules, RNA and gene therapies for central nervous system diseases, liver diseases, lung diseases, cancer, immune system diseases, rare diseases caused by genetic anomalies, kidney diseases, gastrointestinal diseases, and infectious diseases; drug delivery agents in the form of lipid nanoparticles, and sustained and controlled release formulations that facilitate the delivery of pharmaceutical preparations and improve the patients' medication experience

'agent':41 'anomali':31 'cancer':22 'caus':28 'central':14 'control':51 'deliveri':5,40,57 'diseas':17,19,21,25,27,33,35,38 'drug':39 'experi':66 'facilit':55 'form':44 'formul':53 'gastrointestin':34 'gene':11 'genet':30 'immun':23 'improv':62 'infecti':37 'kidney':32 'lipid':46 'liver':18 'lung':20 'medic':65 'molecul':8 'nanoparticl':47 'nervous':15 'patient':64 'pharmaceut':1,59 'prepar':2,60 'rare':26 'releas':52 'rna':9 'small':7 'sustain':49 'system':16,24 'target':4 'therapi':12

pharmaceutical research and development services

'develop':4 'pharmaceut':1 'research':2 'servic':5

METIS

Owners

Goods & Services